Humana Inc · Q4 2020 earnings

Briefing

Humana reported a GAAP loss per share of $2.07 and an adjusted loss per share of $2.30 for Q4 2020. The company provided FY 2021 EPS guidance in the range of $20.82 to $21.32 on a GAAP basis, and $21.25 to $21.75 on an adjusted basis.

Humana reported a loss per common share of $2.07 on a GAAP basis and $2.30 on an Adjusted basis for Q4 2020. The company's results were impacted by COVID-19 treatment and testing costs, crisis relief efforts, strategic investments, and increased marketing expenses. Humana announced FY 2021 EPS guidance in a range of $20.82 to $21.32 on a GAAP basis, $21.25 to $21.75 on Adjusted basis.

• Reported 4Q20 loss per common share of $2.07 on a GAAP basis, $2.30 on an Adjusted basis.
• Announced FY 2021 EPS guidance in a range of $20.82 to $21.32 on a GAAP basis, $21.25 to $21.75 on Adjusted basis.
• Reaffirmed FY 2021 expected individual Medicare Advantage membership growth range of approximately 425,000 to 475,000 members, representing expected year-over-year growth of approximately 11 to 12 percent.
• Experienced a significant increase in COVID-19 admissions in nearly all of the markets in which it operates across its Medicare Advantage, Medicaid, and group commercial insurance business lines.

Headline financials

Revenue & EPS history

Humana provided its GAAP and Adjusted EPS guidance for the year ending December 31, 2021 (FY 2021).